Synfacts, Table of Contents Synfacts 2022; 18(02): 0211DOI: 10.1055/s-0041-1737247 Chemistry in Medicine and Biology Benzoxaborole Inhibitor of CPSF3 for the Treatment of Visceral LeishmaniasisContributor(s): Dirk Trauner , Christopher J. ArpRecommend Article Abstract Buy ArticleKey words Key wordsbenzoxaboroles - visceral leishmaniasis - CPSF3 Full Text